Lipoprotein(a): the underutilized risk factor for cardiovascular disease

Raised lipoprotein(a) [Lp(a)] is an important independent cardiovascular risk factor and predictor of adverse outcomes. Challenges remain with regards to the screening, diagnosis and management of this condition. Although further prospective randomised controlled data is required, there is growing e...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, TZ, Bornstein, SR, Barbir, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Magdi Yacoub Heart Foundation 2019
Materias:
News and Views
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865184/
https://www.ncbi.nlm.nih.gov/pubmed/31799286
http://dx.doi.org/10.21542/gcsp.2019.11
_version_ 1783472037910544384
author Khan, TZ
Bornstein, SR
Barbir, M
author_facet Khan, TZ
Bornstein, SR
Barbir, M
author_sort Khan, TZ
collection PubMed
description Raised lipoprotein(a) [Lp(a)] is an important independent cardiovascular risk factor and predictor of adverse outcomes. Challenges remain with regards to the screening, diagnosis and management of this condition. Although further prospective randomised controlled data is required, there is growing evidence suggesting that lowering Lp(a) may reduce the risk of cardiovascular events and ameliorate symptoms.
format Online
Article
Text
id pubmed-6865184
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Magdi Yacoub Heart Foundation
record_format MEDLINE/PubMed
spelling pubmed-68651842019-12-03 Lipoprotein(a): the underutilized risk factor for cardiovascular disease Khan, TZ Bornstein, SR Barbir, M Glob Cardiol Sci Pract News and Views Raised lipoprotein(a) [Lp(a)] is an important independent cardiovascular risk factor and predictor of adverse outcomes. Challenges remain with regards to the screening, diagnosis and management of this condition. Although further prospective randomised controlled data is required, there is growing evidence suggesting that lowering Lp(a) may reduce the risk of cardiovascular events and ameliorate symptoms. Magdi Yacoub Heart Foundation 2019-09-20 /pmc/articles/PMC6865184/ /pubmed/31799286 http://dx.doi.org/10.21542/gcsp.2019.11 Text en Copyright ©2019 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution license CC BY 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle News and Views
Khan, TZ
Bornstein, SR
Barbir, M
Lipoprotein(a): the underutilized risk factor for cardiovascular disease
title Lipoprotein(a): the underutilized risk factor for cardiovascular disease
title_full Lipoprotein(a): the underutilized risk factor for cardiovascular disease
title_fullStr Lipoprotein(a): the underutilized risk factor for cardiovascular disease
title_full_unstemmed Lipoprotein(a): the underutilized risk factor for cardiovascular disease
title_short Lipoprotein(a): the underutilized risk factor for cardiovascular disease
title_sort lipoprotein(a): the underutilized risk factor for cardiovascular disease
topic News and Views
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865184/
https://www.ncbi.nlm.nih.gov/pubmed/31799286
http://dx.doi.org/10.21542/gcsp.2019.11
work_keys_str_mv AT khantz lipoproteinatheunderutilizedriskfactorforcardiovasculardisease
AT bornsteinsr lipoproteinatheunderutilizedriskfactorforcardiovasculardisease
AT barbirm lipoproteinatheunderutilizedriskfactorforcardiovasculardisease

Ejemplares similares